Increased levels of transcription factors Elk-1, cyclic adenosine monophosphate response element-binding protein, and activating transcription factor 2 in the cerebellar vermis of schizophrenic patients

Archives of General Psychiatry

Volumn 57, Issue 7, 2000, Pages 685-691

  Kyosseva, Svetlana V ^a   Elbein, Alan D ^a   Hutton, Theron L ^a   Griffin, W Sue T ^a,b,c   Mrak, Robert E ^a,c   Sturner, William Q ^a,d   Karson, Craig N ^a,c  

^a Dept of Biochem and Molec Biology ^*  (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^d Stt of Arkansas Med Examiners Off   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CYCLIC AMP; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 2;

ARTICLE; CEREBELLUM VERMIS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; HUMAN; HUMAN TISSUE; SCHIZOPHRENIA; SIGNAL TRANSDUCTION;

EID: 0033936313     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.57.7.685     Document Type: Article

References (47)

1. Katsetos CD,Hyde TM, Herman MM. Neuropathology of the cerebellum in schizophrenia - an update: 1996 and future directions. Biol Psychiatry. 1997;42:213-224.
2. Allen G, Buxton RB, Wong EC, Courchesne E. Attentional activation of the cerebellum of motor involvement. Science. 1997;275:1940-1943.
3. Desmond JE, Fiez JA. Neuroimaging studies of the cerebellum language, learning and memory. Trends Cogn Sci. 1998;2:355-362,
4. Middleton FA, Stick PL. Cerebellar output: motor and cognitive channels. Trends Cogn Sci. 1998;2:348-354.
5. Schmahmann JD. Dysmetria of thought: clinical consequences of cerebellar dysfunction on cognition and affect. Trends Cogn Sci 1998;2:362-371.
6. Volkow ND, Levy A, Brodie JD, Wolf AP, Cancro R, Van Gelder P, Henn F. Low cerebellar metabolism in medicated patients with chronic schizophrenia. Am J Psychiatry. 1992;149:686-688.
7. Crespo-Facorro B, Paradiso S, Andreasen NC, O'Leary DS, Watkins GL, Ponto LL, Hichwa RD. Recalling words lists reveals "cognitive dysmetria" in schizophrenia: a positron emission tomography study. Am J Psychiatry. 1999;156: 386-392.
8. Jacobsen LK, Giedd JN, Berquin PC, Krain AL, Hamburger SD, Kumra S, Rapoport JL. Quantitative morphology of the cerebellum and fourth ventricle in childhood-onset schizophrenia. Am J Psychiatry. 1997;154:1663-1669.
9. Wassink TH, Andreasen NC, Nopoulos P, Flaum M. Cerebellar morphology as a predictor of symptom and psychosocial outcome in schizophrenia. Biol Psychiatry. 1999;45:41-48.
10. Tran KD, Smutzer GS, Doty RL, Arnold SE. Reduced Purkinje cell size in the cerebellar vermis of elderly patients with schizophrenia. Am J Psychiatry. 1998; 155:1288-1290.
11. Karson CN, Griffin WS, Mrak RE, Husain M, Dawson TM, Snyder SH, Moore NC, Sturner WQ. Nitric oxide synthase (NOS) in schizophrenia: increases in cerebellar vermis. Mol Chem Neuropathol. 1996;27:275-284.
12. Kyosseva SV, Elbein AD, Griffin WS, Mrak RE, Lyon M, Karson CN, Mitogen-activated protein kinases in schizophrenia. Biol Psychiatry. 1999;46:589-696.
13. Miyasaka T, Chao MV, Sherline P, Saltiel AR. Nerve growth factor stimulates a protein kinase in PC-12 cells that phosphorylate microtubile-associated protein-2. J Biol Chem. 1990;265:4730-4735.
14. Boulton TG, Nye SH, Robbins DJ, Ip NY, Radziejewska E, Morgenbesser SD, De-Pinho RA, Panayotatos N, Cobb MH, Yancopoulos GD. ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in responses to insulin and NGF. Cell. 1991;65:663-675.
15. Bading H, Greenberg ME. Stimulation of protein tyrosine phosphorylation by NMDA receptor activation. Science. 1991;253:912-914.
16. Fiore RS, Murphy TH, Sanghera JS, Pelech SL, Baraban JM. Activation of p42 mitogen-activated protein kinase by glutamate receptor stimulation in rat primary cortical cultures. J Neurochem. 1993;61:1626-1633.
17. Kurino M, Fukunaga K, Ushio Y, Miyamoto E. Activation of mitogen-activated protein kinase in cultured rat hippocampal neurons by stimulation of glutamate receptors. J Neurochem. 1995;65:1282-1289.
18. Xia Z, Dudek H, Miranti CK, Greenberg ME. Calcium influx via the NMDA receptor induces immediate early gene transcription by a MAP kinase/ERK-dependent mechanism. J Neurosci. 1996;16:5425-5436.
19. Vanhoutte P, Barnier JV, Guibert B, Pages C, Besson MJ, Hipskind RA, Caboche J. Glutamate induces phosphorylation of Elk-1 and CREB, along with c-fos activation, via an extracellular signal-regulated kinase-dependent pathway in brain slices. Mol Cell Biol. 1999;19:136-146.
20. Rosenblum K, Futter M, Jones M, Hulme EC, Bliss TV. ERKI/II regulation by the muscarinic acetylcholine receptors in neurons. J Neurosci. 2000;20:977-985.
21. Kanterewicz BI, Knapp LT, Klann E. Stimulation of p42 and p44 mitogen-activated protein kinases by reactive oxygen species and nitric oxide in hippocampus. J Neurochem. 1998;70:1009-1016.
22. Lewis TS, Shapiro PS, Ahn NG. Signal transduction through MAP kinase cascades. Adv Cancer Res. 1998;74:49-139.
23. Guan KL. The mitogen activated protein kinase signal transduction pathway: from the cell surface to the nucleus. Cell Signal. 1994;6:581-589.
24. Berman DE, Hazvi S, Rosenblum K, Seger R, Dudai Y. Specific and differential activation of mitogen-activated protein cascades by unfamiliar taste in the insular cortex of the behaving rat. J Neurosci. 1998;18:10037-10044.
25. Blurn S, Moore AN, Adams F, Dash PK. A mitogen-activated protein cascade in the CA1/CA2 subfield of the dorsal hippocampus is essential for long-term spatial memory. J Neurosci. 1999;19:3535-3544.
26. Impey S, Obrietan K, Storm DR. Making new connections: role of ERK/MAP kinase signaling in neuronal plasticity. Neuron. 1999;23:11-14.
27. Sgambato V, Vanhoutte P, Pages C, Rogard M, Hipskind R, Besson MJ, Caboche J. In vivo expression and regulation of Elk-1, a target of the extracellular-regulated kinase signaling pathway, in the adult rat brain. J Neurosci. 1998;18: 214-226.
28. Sgambato V, Pages C, Rogard M, Besson MJ, Caboche J. Extracellular signal-regulated kinase (ERK) controls immediate early gene induction on corticostriatal stimulation. J Neurosci. 1998;18:8814-8825.
29. Salzman S, Endicott J, Clayton P, ed. Diagnostic Evaluation After Death (DEAD). Rockville, Md: National Institute of Mental Health Neuroscience Research Branch; 1983.
30. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition. Washington, DC: American Psychiatric Association; 1987.
31. Karson CN, Casanova MF, Kleinman JE, Griffin WS. Choline acetyltransferase in schizophrenia. Am J Psychiatry. 1993;150:454-459.
32. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, Van Belle G, Berg L. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part II: standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 1991;41:479-486.
33. Hassanain HH, Dai W, Gupta SL. Enhanced gel mobility shift assay for DNA binding factors. Anal Biochem. 1993;15:162-167.
34. Beckmann AM, Mastsumoto I, Wilce PA. AP-1 and Egr DNA-binding activities are increased in rat brain during ethanol withdrawal. J Neurochem. 1997;69: 306-314.
35. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
36. Siegel S. Nonparametric Statistics for the Behavioral Sciences, New York, NY: McGraw-Hill Book Co; 1956. Harlow HF, ed. McGraw-Hill Series in Psychology.
37. Dowlatshahi D, MacQueen GM, Wang JF, Young LT. Increased temporal cortex CREB concentrations and antidepressant treatment in major depression. Lancet. 1998;352:1754-1755.
38. Dowlatshahi D, MacQueen GM, Wang JF, Reiach JS, Young LT. G-protein-coupled cyclic AMP signaling in postmortem brain of subjects with mood disorders: effects of diagnosis, suicide, and treatment at the time of death. J Neurochem. 1999;73:1121-1126.
39. Herdegen T, Leah JD. Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins. Brain Res Rev. 1998;28:370-490.
40. Imaki J, Yoshida K, Yamashita K. A developmental study of cyclic AMP-response element binding protein (CREB) by in situ hybridization histochemistry and immunocytochemistry in the rat neocortex. Brain Res. 1994;651:269-274.
41. Ginty DD, Kornhauser JM, Thompson MA, Bading H, Mayo KE, Takahashi JS, Greenberg ME. Regulation of CREB phosphorylation in the suprachiasmatic nucleus by light and circadian clock. Science. 1993;260:238-241.
42. Bourtchuladze R, Frenguelli B, Blendy J, Cioffi D, Schutz G, Silva AJ. Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein. Cell. 1994;79:59-68.
43. Silva AJ, Kogan JH, Frankland PW, Kida S. CREB and memory. Annu Rev Neurosci. 1998;21:127-148.
44. Lamprecht M. CREB: a message to remember. Cell Mol Life Sci. 1999;55:554-563.
45. De Cesare D, Jacquot S, Hanauer A, Sassone-Corsi P. Rsk-2 activity is necessary for epidermal growth factor-induced phosphorylation of CREB protein and transcription of c-fos gene. Proc Natl Acad Sci U S A. 1998;95:12202-12207.
46. Kara CJ, Liou HC, Ivashkiv LB, Glimcher LH. A cDNA for a human cyclic AMP response element-binding protein which is distinct from CREB and expressed preferentially in the brain. Mol Cell Biol. 1990;10:1347-1357.
47. Takeda J, Maekawa T, Sudo T, Seino Y, Imura H, Saito N, Tanaka C, Ishii S. Expression of the CRE-BP1 transcriptional regulator binding to the cyclic AMP response element in central nervous system, regenerating liver, and human tumors. Oncogene. 1991;6:1009-1014.